Hereditary Breast Cancer Gene Mutation Panel, NGS (BreastNext®)
Alternaria tenuis, IgE
Interferon-γ Receptor (IFNGR1) Deficiency
Biopsy, Bile Duct
Gastrointestinal Parasite Pathogen Panel, Molecular
Tumor Necrosis Factor Receptor-Ass Periodic Syndrome (TNFRSF1A) Gene Mutation Analysis
Culture, Eye (Routine)
Biopsy, Lung
Acid-Fast Bacillus (AFB) Stain, Reflex to Culture, Sputum
Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis

LDS
Sign up
Log in

LDS
/Medical Tests
/Prosigna Breast Cancer Prognostic Gene Signature

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

Clinical Utility

Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.